Starting from 2023, where the nervous system medicine sales in Italy were positioned at 57.0 US Dollars PPP Per Capita, the forecasts for the subsequent years represent a consistent growth pattern: 2024 sees an increase to 59.9, 2025 reaches 62.9, further growing to 65.8 in 2026, followed by 68.8 in 2027, and finally 71.7 in 2028. The year-on-year growth percentages highlight a steady annual increase, with the Compound Annual Growth Rate (CAGR) over this five-year period demonstrating a robust long-term growth trajectory.
Future trends to watch for include:
- The impact of aging population demographics on nervous system medicine demand.
- Advancements in medical research potentially leading to new treatments.
- Economic fluctuations affecting healthcare budgets and expenditure.
- Regulatory changes and their effects on market dynamics.
